. 2011 Apr 8;22(9):1143–1153. doi: 10.1089/hum.2010.245

Table 1.

Constructs Packaged in AAV

Construct	Enhancer	Promoter	Intron	Poly(A)
CMV-GFP	CMV early^a	CMV early^b	Chimeric hβ-Globin^c/mIgG^d	SV40 early^e
CBA-GFP	CMV early^a	chβ-Actin^f	Truncated SV40 late 16S^g	BGH^h
CBh-GFP	CMV early^a	chβ-Actin^f	Chimeric chβ-Actinⁱ/MVM^j	BGH^h
MeP-GFP	NA	mMeCP2^k	NA	Synthetic^l

NA, not applicable; for other abbreviations see text.

^{^a}

GenBank accession no. NC_006273.2, nt 175625–175294.

^{^b}

GenBank accession no. NC_006273.2, nt 175043–175294.

^{^c}

GenBank accession no. AC_000054.1, nt 5366740–5366826.

^{^d}

GenBank accession no. L26879.1, nt 678–705.

^{^e}

GenBank accession no. NC_001669.1, nt 2548–2774.

^{^f}

GenBank accession no. X00182.1, nt 280–540.

^{^g}

GenBank accession no. NC_001669.1, nt 502–561, 1410–1497.

^{^h}

Bovine growth hormone, GenBank accession no. EF592533.1, nt 1827–2034.

^ⁱ

GenBank accession no. X00182.1, nt 544–676.

^{^j}

GenBank accession no. NC_001510.1, nt 2312–2403 (VP intron).

^{^k}

See Adachi et al. (2005), nt−170 to+53 from mapped transcription start.

^{^l}

Synthetic, based on Levitt et al. (1989).